Relates to classifying U-47700 (Pink) as a schedule I opiate

Title of bill

An act to amend the public health law, in relation to classifying U-47700, more commonly known as "Pink," as a schedule I opiate

Purpose

This bill adds U-4770, commonly known as "Pink", as a schedule opiate controlled drug, criminalizing possession and sale of the drug.

Summary of provisions

Section 1: amends subdivision (b) of schedule I of section 3306 of the public health law by adding a new paragraph 56.

Section 2: sets the effective date.

Justification

While New York has recently passed legislation addressing the opiate epidemic, synthetic opiate drugs also remain a problem. These drugs often infiltrate communities, causing public health problems. Recently, a new synthetic opiate, U-47700, commonly referred to as "Pink", has spread in popularity across the United States. "Pink" is reportedly eight times more powerful than heroin; a dose is available for purchase over the internet for as little as $5; and is so dangerous that merely touching the drug with bare skin is dangerous to humans.* As of October 2016, the US Drug Enforcement Agency (DEA) has identified 15 deaths nationwide attributed to using "Pink", however the agency believes this number is probably higher.* While the DEA has already started the process to classify "Pink" as a controlled substance, New York has not yet done so, meaning the purchase and sale of the drug is not yet prohibited under state law.

This bill would classify the synthetic drug U-47700, known as "Pink", as a schedule I opiate. By classifying "Pink" as a schedule I opiate, possession and sale of the drug will be criminalized under New York law, helping to stop the spread of "Pink" across our state and potentially harming or killing New Yorkers.

*http://www.nbcnews.com/storyline/americas-heroin-epidemic/pink- strongerheroin-legal-most-states-n666446

Legislative history

New Bill.

Fiscal implications

None

Effective date

This act shall take effect immediately.